APA (7th ed.) Citation

JA, H., NS, A., KA, H., S, H., A, K., B, B., . . . R, M. (2026). Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system. Frontiers in public health, 14, 1800784. https://doi.org/10.3389/fpubh.2026.1800784

Chicago Style (17th ed.) Citation

JA, Hamida, Alkhatib NS, Hammour KA, Halloush S, Kurdi A, Balkhi B, Alfayez OM, and Mousa R. "Budget Impact Analysis of the Introduction of Ranibizumab's Biosimilar to the Jordanian Joint Procurement System." Frontiers in Public Health 14 (2026): 1800784. https://doi.org/10.3389/fpubh.2026.1800784.

MLA (9th ed.) Citation

JA, Hamida, et al. "Budget Impact Analysis of the Introduction of Ranibizumab's Biosimilar to the Jordanian Joint Procurement System." Frontiers in Public Health, vol. 14, 2026, p. 1800784, https://doi.org/10.3389/fpubh.2026.1800784.